エピソード

  • Exercise, Insulin and Automation. The challenges.

    Exercise, Insulin and Automation. The challenges.
    2024/11/02
    In this episode, Mac and Lin discuss the challenges of managing exercise with automated insulin delivery systems. https://www.diabettech.com/insulin/exercise-insulin-and-automation-the-challenges/
    続きを読む 一部表示
    8 分
  • The wild, wild, west of the CGM head to head study

    The wild, wild, west of the CGM head to head study
    2024/10/31
    In this episode, we discover that Lin also has type 1 and Mac and Lin discuss the head to head study between the Abbott Libre3 and Dexcom G7 study published in the Journal of Diabetes Science and Technology in March and highlight some of the challenges with it. https://www.diabettech.com/cgm/welcome-to-the-wild-wild-west-the-cgm-head-to-head-study/
    続きを読む 一部表示
    11 分
  • GLP1-RAs and Type 1 Diabetes: Real world use with Automated insulin delivery systems

    GLP1-RAs and Type 1 Diabetes: Real world use with Automated insulin delivery systems
    2024/10/17
    This episode discusses the findings a small study looking at incretin-based therapy used by people with type 1 diabetes who are also using Open Source Automated delivery systems.
    続きを読む 一部表示
    9 分
  • GLP1-RAs and Type 1 Diabetes: dosing schedules and Pharmacokinetics

    GLP1-RAs and Type 1 Diabetes: dosing schedules and Pharmacokinetics
    2024/10/11
    In this episode, Mac and Lin dig into the pharmacokinetics of incretins and how they might affect glucose management in type 1 diabetes. Original Source: https://wp.me/p7O2EL-2t0
    続きを読む 一部表示
    10 分
  • Using smart device data to gain an insight into life with diabetes

    Using smart device data to gain an insight into life with diabetes
    2024/10/10
    This episode discusses a couple of posts on diabettech.com that dive into the data derived from CGM, pump and smart watch and offers some ideas on how that might help with diabetes management. Sources: https://www.diabettech.com/biological-data/diabetes-and-data-what-more-can-we-learn-part-1/ https://www.diabettech.com/biological-data/diabetes-and-data-what-more-can-we-learn-part-2/
    続きを読む 一部表示
    9 分
  • Open Source Automated Insulin Delivery. Looking at the choice and why it matters.

    Open Source Automated Insulin Delivery. Looking at the choice and why it matters.
    2024/10/10
    This episode looks at Loop and AndroidAPS, published studies on their performance and a study on pigs that compared the algorithms and discussed why options are important and how these open source solutions are safe. Source Data at: https://pubmed.ncbi.nlm.nih.gov/33226840/ https://www.nejm.org/doi/full/10.1056/NEJMoa2203913 https://www.diabettech.com/artificial-pancreas/automated-insulin-delivery-why-choice-matters/
    続きを読む 一部表示
    11 分
  • To patch pump or not patch pump?

    To patch pump or not patch pump?
    2024/10/10
    A look at the differences between the types of pump and some of the non-obvious reasons why you might want to choose one or the other. To note: Google's AI wasn't quite aware of what tunneling is... https://www.diabettech.com/patch-pump/to-patch-pump-or-not-to-patch-pump-that-is-the-question/
    続きを読む 一部表示
    12 分
  • GLP1 Receptor Agonists and Type 1 Diabetes: More than meets the eye?

    GLP1 Receptor Agonists and Type 1 Diabetes: More than meets the eye?
    2024/10/10
    This episode features a discussion on GLP1-RAs, what they do physiologically and how they might affect Type 1 Diabetes.
    続きを読む 一部表示
    15 分